Growth Metrics

Eli Lilly (LLY) EBT Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2,301.00
Dec 31, 2025 966.00
Sep 30, 2025 1,606.00
Jun 30, 2025 1,367.00
Mar 31, 2025 -152.00
Dec 31, 2024 1,003.00
Sep 30, 2024 -1,178.00
Jun 30, 2024 511.00
Mar 31, 2024 1,457.00
Dec 31, 2023 1,029.00
Sep 30, 2023 -2,077.00
Jun 30, 2023 2,438.00
Mar 31, 2023 -553.00
Dec 31, 2022 2,236.00
Sep 30, 2022 1,210.00
Jun 30, 2022 -483.00
Mar 31, 2022 2,512.00
Dec 31, 2021 751.00
Sep 30, 2021 -31.00
Jun 30, 2021 617.00
Mar 31, 2021 1,004.00
Dec 31, 2020 2,492.00
Sep 30, 2020 391.00
Jun 30, 2020 1,624.00
Mar 31, 2020 1,536.00
Dec 31, 2019 1,717.00
Sep 30, 2019 1,222.00
Jun 30, 2019 695.00
Mar 31, 2019 -466.00
Dec 31, 2018 86.00
Sep 30, 2018 -95.00
Jun 30, 2018 -2,480.00
Mar 31, 2018 -732.00
Dec 31, 2017 -1,064.00
Sep 30, 2017 -2,398.00
Jun 30, 2017 47.00
Mar 31, 2017 -2,267.00
Dec 31, 2016 -174.00
Sep 30, 2016 -574.00
Jun 30, 2016 -701.00
Mar 31, 2016 -1,017.00
Dec 31, 2015 -1,451.00
Sep 30, 2015 -933.00
Jun 30, 2015 -1,742.00
Mar 31, 2015 -1,783.00
Dec 31, 2014 -913.00
Sep 30, 2014 -641.00
Jun 30, 2014 -868.00
Mar 31, 2014 -1,433.00